RxDoctor Payments Data

Matthew Hopson

Podiatrist · Williamsburg, VANPI 1164692877

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (34.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Linvatec Corporation at 35.2% of the total. Among podiatrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,179in general payments, 2019–2025

Across 117 payments — averaging $377.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$16K
  • Integra Lifesciences Corporation$12K
  • Ascension Orthopedics, Inc.$7K
  • Trimed, Inc.$4K
  • In2bones USA, LLC$3K
  • Osteomed LLC$1K
  • plus $1K from 20 others

What the payments were for

  • Royalty or licence$3,1007%
  • Consulting fees$11,50026%
  • Speaking & faculty fees$15,31035%
  • Travel & lodging$10,69024%
  • Food & beverage$3,5438%
  • Entertainment$350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,179 in reported general payments places this provider in the 95th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$425,205
Medicare patients
699
Services billed
2,576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib22$517
Methylprednisolone75$401
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$296
Cephalexin25$141
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$135
Diclofenac Sodium21$77
Meloxicam14$61

Paid to pharmacies, not to this prescriber.

Other podiatrist in Williamsburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →